A Study on the Treatment of Parkinson's Disease With Autologous Neural Stem Cells

Inclusion Criteria

• •1. The subject is able to understand the research requirements, provide written informed consent, and complete the study in accordance with the procedures;
• •2. The subject is clearly diagnosed with Parkinson's;
• •3. Recorded disease progression over the past 6 months;
• •4. Vital organ function is satisfied: cardiac ultrasound indicates cardiac ejection fraction ≥ 50%, no obvious abnormality in ECG; blood oxygen saturation ≥ 90%; creatinine clearance calculated by Cockcroft-Gault formula ≥ 40ml/min; ALT and AST ≤ 3 times the normal range, total bilirubin ≤ 2.0 mg/dl;
• •5. Blood routine: Hgb≥80g/L, ANC≥1×109/L, PLT≥50×10/L;